Chemed CEO Kevin Mcnamara sold 2,000 shares of the company's stock for approximately $1.0 million, reducing his stake by 2.84%. Following the sale, Chemed's shares fell by 1.3%, though the company recently reported strong quarterly earnings that surpassed estimates and increased its quarterly dividend. Institutional investors hold a significant portion of the stock, and analysts currently have a consensus "Hold" rating with an average price target of $530.75.

Wells Fargo has significantly increased its price target for Meta Platforms from $640 to $796, reiterating an Overweight rating, based on strong AI product momentum and early success of the Meta Muse assistant. The firm points to a 60% jump in daily assistant users since Muse Spark integration and expects Meta Connect to highlight these usage statistics. This upgrade reinforces a rebuilding bull case for Meta, particularly for long-term investors, despite some near-term risks like compressed operating margins and a surge in capital expenditures.

Moderna's stock surged after proving the efficacy of its personalized cancer vaccine, intismeran autogene. The company is now preparing to present three abstracts for this mRNA cancer vaccine at the European Society for Medical Oncology's annual meeting, signaling a major upcoming test for the drug. Investors are keenly watching the next developments for this promising treatment.

The Detroit Tigers and Fifth Third Bank are anticipated to announce a name change for Comerica Park on Monday, September 21, 2026, before the Tigers' game against the Washington Nationals. This expected change follows Fifth Third Bank's acquisition merger of Comerica Bank nearly a year ago, leading to speculation about the stadium's naming rights. Comerica Park has been the home of the Tigers since 2000, and this season is likely its last under that name.

Marathon Petroleum (NYSE:MPC) is gaining attention due to tightening fuel supplies, changes in West Coast refinery capacity, and varied valuation assessments. The company's integrated operations, including refining, marketing, midstream infrastructure, and renewable fuels, position it uniquely within the evolving U.S. energy sector. The debate over its valuation highlights the impact of assumptions about refining margins and operating conditions on financial models.

Citigroup has adjusted its price target for Cintas Corporation (CTAS) to $180, an increase from its previous target of $175. This update was reported on September 21, 2026. The article notes that this content is reserved for members.

Moderna will present detailed Phase 3 results for its personalized cancer therapy, Intismeran, at the ESMO Congress on October 24, 2026. This therapy, developed with Merck, previously showed significant improvements in melanoma recurrence-free and distant metastasis-free survival when combined with Keytruda. Retail investors are increasingly optimistic about Moderna's stock, with some believing this cancer therapy could be revolutionary.

PNC Bank has appointed Jeni Cooper as the new vice president and market manager for community development banking. Based in Pittsburgh, Cooper will lead community development banking teams across central and western Pennsylvania. She previously worked at PNC for nearly five years.

Datadog Inc (DDOG) stock increased by 5.14% on September 21, driven by renewed institutional buying and strong adoption of its cloud observability and security platform. Analysts maintain "Buy" ratings with an average price target of $284.22, despite some technical indicators suggesting an overbought condition and risks related to customer concentration and high valuation multiples. The company's AI-driven capabilities and strategic role in cloud infrastructure are seen as key growth drivers.

Gartner predicts that by 2027, 60% of organizations failing to address cultural challenges in data and analytics governance will also fail to govern AI successfully. A Gartner survey revealed that cultural resistance, rather than funding, is the primary reason governance initiatives fail. To improve AI governance, Gartner advises D&A leaders to align governance with business outcomes, rebrand data governance as a collaborative effort, and embed it into daily workflows.